Home / REKA.TA : TLV

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does REKA.TA make money? Does REKA.TA have pricing power? What's the Earnings Whisper? Will REKA.TA profit more as the business scales? What is REKA.TA's management track record? Is REKA.TA's current price justified?

Rekah Pharmaceutical Industry Ltd.

ILA 1020.00 -$73.00 (-6.68%)

TLV · 30 Oct 2026 11:44 UTC

Previous Close

ILA 1020.00

Day Range

ILA 1020.00ILA 1048.00

Year Range

ILA 1006.00ILA 1348.00

Market Cap

116.43M

AVG Volume

3.57K

Trailing/Forward PE

-7.34/-

PEG ratio

0.28

Dividend Yield

Next Earnings Date

Primary Exchange

Tel Aviv Stock Exchange

Revenue (ILS) · A

REKA.TA Revenue (ILS) by year
Period	Revenue (ILS)
2025	300.99M
2024	321.71M
2023	321.66M
2022	292.39M
2021	263.95M
2020	265.47M
2019	198.6M
2018	207.83M
2017	208.18M
2016	218.38M

Net Income (ILS) · A

REKA.TA Net Income (ILS) by year
Period	Net Income (ILS)
2025	-18.07M
2024	6.21M
2023	-6.91M
2022	-2.04M
2021	6.62M
2020	10.8M
2019	3.99M
2018	7.02M
2017	-22.48M
2016	-11M

Operating Income (ILS) · A

REKA.TA Operating Income (ILS) by year
Period	Operating Income (ILS)
2025	-6.45M
2024	16.37M
2023	2.91M
2022	12.43M
2021	14.14M
2020	20.92M
2019	11.37M
2018	14.22M
2017	11.6M
2016	7.46M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (ILS) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Rekah Pharmaceutical Industry Ltd.

Earnings: REKA.TA

Video analysis: REKA.TA

News: REKA.TA

Similar companies